98%
921
2 minutes
20
Unlike the bacterial microbiome, the role of early-life gut fungi in host metabolism and childhood obesity development remains poorly characterized. To address this, we investigate the relationship between the gut mycobiome of 100 infants from the Canadian Healthy Infant Longitudinal Development (CHILD) Cohort Study and body mass index Z scores (BMIz) in the first 5 years of life. An increase in fungal richness during the first year of life is linked to parental and infant BMI. The relationship between richness pattern and early-life BMIz is modified by maternal BMI, maternal diet, infant antibiotic exposure, and bacterial beta diversity. Further, the abundances of Saccharomyces, Rhodotorula, and Malassezia are differentially associated with early-life BMIz. Using structural equation modeling, we determine that the mycobiome's contribution to BMIz is likely mediated by the bacterial microbiome. This demonstrates that mycobiome maturation and infant growth trajectories are distinctly linked, advocating for inclusion of fungi in larger pediatric microbiome studies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975311 | PMC |
http://dx.doi.org/10.1016/j.xcrm.2023.100928 | DOI Listing |
PLoS Biol
September 2025
One Health Microbiome Center, Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, Pennsylvania, United States of America.
Human genetic determinants of the gut mycobiome remain uninvestigated despite decades of research highlighting tripartite relationships between gut bacteria, genetic background, and disease. Here, we present the first genome-wide association study on the number and types of human genetic loci influencing gut fungi relative abundance. We detect 148 fungi-associated variants (FAVs) across 7 chromosomes that statistically associate with 9 fungal taxa.
View Article and Find Full Text PDFiScience
August 2025
School of Chemical Engineering, Sungkyunkwan University, Suwon, Republic of Korea.
Pediatric-onset Crohn's disease (pCD) is characterized by frequent relapses and long-term impacts on growth, requiring targeted strategies for disease monitoring and treatment. To characterize gut microbiome and mycobiome changes in pCD, we profiled bacterial and fungal communities across multiple gastrointestinal (stool, colon, and terminal ileum) in 30 pre- and post-treatment patients and 36 healthy controls. Microbial shifts in mucosal biopsies lagged behind those in stool, indicating site-specific responsiveness to treatment.
View Article and Find Full Text PDFVirulence
December 2025
Department of Colorectal and Anal Surgery, Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
The gut mycobiota, a minor but influential component of the microbiota, is increasingly recognized for its role in shaping host immunity and influencing health. Advances in sequencing technologies have now highlighted the diversity and complexity of these fungal communities. Dysbiosis of the gut mycobiota is associated with various diseases, including inflammatory bowel disease (IBD) and asthma, through mechanisms involving fungal-host interactions, immune modulation, and cross-reactivity.
View Article and Find Full Text PDFBMC Microbiol
August 2025
Department of Biology, University of Florence, Sesto Fiorentino, Florence, 50019, Italy.
Background: The phenomenon of urbanization is associated with significant shifts in lifestyle and dietary habits, which can impact the composition of gut microbiota. While variations in gut bacterial communities between rural and urban residents are documented, changes in fungal communities (mycobiota) remain underexplored. This study investigates the impact of urbanization-related dietary shifts on the gut mycobiota in a sub-Saharan African context (Burkina Faso).
View Article and Find Full Text PDFISME J
August 2025
Department of Infectious Diseases & Anhui Center for Surveillance of Bacterial Resistance, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Escalating antibiotic resistance of Klebsiella pneumoniae underscores the urgent need for therapeutic strategies. Whereas gut bacterial dysbiosis exacerbates pulmonary infections, the role of gut fungi in modulating lung immunity remains understudied. Here, we demonstrate that antibiotic-induced gut fungal expansion aggravates pneumonia by enhancing alveolar macrophage-driven inflammation via Dectin-1 signaling.
View Article and Find Full Text PDF